Obroniecka I, Rojewska J, Wańkowicz Z
Kliniki Nefrologii ze Stacja Dializ, Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej.
Pol Merkur Lekarski. 1998 Nov;5(29):285-7.
In order to improve early diagnosis of urotheliale neoplasms (UN) in nephrology outpatient clinic, 274 patients (221 male and 53 female, mean age 54 yrs), with recurrent hematuria (> 5 E/hpf) were investigated in years 1994-1998. The following examinations of fresh urine sediment were performed: in 114pts (group 1) erythrocytes of urine sediment examined with phase-contrast microscopy (PCM); in 129pts (group II) urine sediment examined with classical oncological cytology; in the III-rd group of 31pts (29M and 2F, aged 61-72), both methods were used because of high suspicion on UN on the ground of initial result of PCM, precisely clinical anamnesis as well as predominance of men in advanced age. Results were as follows. In the I-st group, in 6 from 42pts with urological hematuria in PCM, what means 5.2% of the whole group and 14% of the subgroup with urological hematuria, in further standard urological examination bladder carcinoma was found. In the II-nd group, positive result of urinary cytology (GI to GIII) was found in 7pts, what means 5.4% of the whole group. Results of urine cytology were confirmed later in the standard urological examination, which detected bladder carcinoma in all these patients. In the III-rd group, bladder carcinoma was found in all 22pts with urological hematuria in PCM. In 19 patients from this subgroup, urinary cytology was positive for UN (GI to GIII). In the remaining 3pts results of urinary cytology were false negative. False positive result of urinary cytology occurred in one from 9pts with glomerular hematuria and clinical or morphological (in renal biopsy) evidence of glomerulonephritis. On the results of the study, we propose--as an obligatory--in every case of recurrent hematuria of urological origin in PCM, examination of fresh urinary sediment with classical oncological cytology, especially if the patient belongs to the high risk group for urotheliale neoplasms.
为提高肾脏病门诊尿路上皮肿瘤(UN)的早期诊断率,1994年至1998年对274例复发性血尿(>5个红细胞/高倍视野)患者(221例男性,53例女性,平均年龄54岁)进行了调查。对新鲜尿沉渣进行了以下检查:114例患者(第1组)采用相差显微镜(PCM)检查尿沉渣中的红细胞;129例患者(第II组)采用经典肿瘤细胞学检查尿沉渣;第III组31例患者(29例男性,2例女性,年龄61 - 72岁),由于PCM初步结果高度怀疑为UN,具体为临床病史以及老年男性居多,因此两种方法都使用了。结果如下。在第1组中,PCM检查的42例泌尿系统血尿患者中有6例,占整个组的5.2%,泌尿系统血尿亚组的14%,在进一步的标准泌尿系统检查中发现了膀胱癌。在第II组中,7例患者尿细胞学检查结果为阳性(GI至GIII),占整个组的5.4%。尿细胞学检查结果随后在标准泌尿系统检查中得到证实,所有这些患者均检测出膀胱癌。在第III组中,PCM检查的所有22例泌尿系统血尿患者均发现了膀胱癌。该亚组中的19例患者尿细胞学检查UN为阳性(GI至GIII)。其余3例患者尿细胞学检查结果为假阴性。9例肾小球性血尿且有临床或形态学(肾活检)证据支持肾小球肾炎的患者中有1例尿细胞学检查结果为假阳性。根据研究结果,我们建议——作为一项必做检查——对于PCM检查中每一例泌尿系统来源的复发性血尿患者,尤其是如果患者属于尿路上皮肿瘤高危组,采用经典肿瘤细胞学检查新鲜尿沉渣。